MicroRNAs as biomarkers for CNS cancer and other disorders

Brain Research

Volumn 1338, Issue , 2010, Pages 100-111

  De Smaele, Enrico ^a   Ferretti, Elisabetta ^a   Gulino, Alberto ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

Glioma; Medulloblastoma; miRNA; Neurodegeneration; Tumors

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 124; MICRORNA 125A; MICRORNA 128; MICRORNA 153; MICRORNA 21; MICRORNA 31; MICRORNA 9; ONCOGENE MICRORNA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AUTISM; BODY FLUID; CANCER DIAGNOSIS; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM TUMOR; DEGENERATIVE DISEASE; DOWN REGULATION; EARLY DIAGNOSIS; GENE EXPRESSION; GENE LOCATION; GLIOMA; HUMAN; HUNTINGTON CHOREA; MEDULLOBLASTOMA; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RNA ANALYSIS; SCHIZOPHRENIA; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; MICRORNAS; SPINAL CORD NEOPLASMS;

EID: 77952583639     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.03.103     Document Type: Review

References (117)

1. Abu-Elneel K., Liu T., Gazzaniga F.S., Nishimura Y., Wall D.P., Geschwind D.H., Lao K., and Kosik K.S. Heterogeneous dysregulation of microRNAs across the autism spectrum. Neurogenetics 9 (2008) 153-161
2. Abu-Elneel K., Liu T., Gazzaniga F.S., Nishimura Y., Wall D.P., Geschwind D.H., Lao K., and Kosik K.S. Reply to the "Letter to the Editors" by Steven Buyske. Neurogenetics 10 (2009) 169-170
3. Ai J., Zhang R., Li Y., Pu J., Lu Y., Jiao J., Li K., Yu B., Li Z., Wang R., Wang L., Li Q., Wang N., Shan H., and Yang B. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem. Biophys. Res. Commun. (2009)
4. Ambros V. The functions of animal microRNAs. Nature 431 (2004) 350-355
5. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., and Bartel D.P. The impact of microRNAs on protein output. Nature 455 (2008) 64-71
6. Bak M., Silahtaroglu A., Moller M., Christensen M., Rath M.F., Skryabin B., Tommerup N., and Kauppinen S. MicroRNA expression in the adult mouse central nervous system. Rna 14 (2008) 432-444
7. Barbato C., Ciotti M.T., Serafino A., Calissano P., and Cogoni C. Dicer expression and localization in post-mitotic neurons. Brain Res. 1175 (2007) 17-27
8. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 136 (2009) 215-233
9. Beveridge N.J., Tooney P.A., Carroll A.P., Gardiner E., Bowden N., Scott R.J., Tran N., Dedova I., and Cairns M.J. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum. Mol. Genet. 17 (2008) 1156-1168
10. Blennow K., de Leon M.J., and Zetterberg H. Alzheimer's disease. Lancet 368 (2006) 387-403
11. Boissonneault V., Plante I., Rivest S., and Provost P. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J. Biol. Chem. 284 (2009) 1971-1981
12. Buyske S. Comment on the article "Heterogeneous dysregulation of microRNAs across the autism spectrum" by Abu-Elneel et al. Neurogenetics 10 (2009) 167
13. Calin G.A., and Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6 (2006) 857-866
14. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., Aldler H., Rattan S., Keating M., Rai K., Rassenti L., Kipps T., Negrini M., Bullrich F., and Croce C.M. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 15524-15529
15. Cao X., Yeo G., Muotri A.R., Kuwabara T., and Gage F.H. Noncoding RNAs in the mammalian central nervous system. Annu. Rev. Neurosci. 29 (2006) 77-103
16. Castoldi M., Schmidt S., Benes V., Hentze M.W., and Muckenthaler M.U. miChip: an array-based method for microRNA expression profiling using locked nucleic acid capture probes. Nat. Protoc. 3 (2008) 321-329
17. Chan J.A., Krichevsky A.M., and Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65 (2005) 6029-6033
18. Chekulaeva M., and Filipowicz W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr. Opin. Cell Biol. 21 (2009) 452-460
19. Chen C.Z. MicroRNAs as oncogenes and tumor suppressors. N. Engl. J. Med. 353 (2005) 1768-1771
20. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo X., Li Q., Li X., Wang W., Zhang Y., Wang J., Jiang X., Xiang Y., Xu C., Zheng P., Zhang J., Li R., Zhang H., Shang X., Gong T., Ning G., Wang J., Zen K., Zhang J., and Zhang C.Y. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18 (2008) 997-1006
21. Ciafre S.A., Galardi S., Mangiola A., Ferracin M., Liu C.G., Sabatino G., Negrini M., Maira G., Croce C.M., and Farace M.G. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun. 334 (2005) 1351-1358
22. Cogswell J.P., Ward J., Taylor I.A., Waters M., Shi Y., Cannon B., Kelnar K., Kemppainen J., Brown D., Chen C., Prinjha R.K., Richardson J.C., Saunders A.M., Roses A.D., and Richards C.A. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis. 14 (2008) 27-41
23. Conaco C., Otto S., Han J.J., and Mandel G. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2422-2427
24. Corsten M.F., Miranda R., Kasmieh R., Krichevsky A.M., Weissleder R., and Shah K. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res. 67 (2007) 8994-9000
25. Cortez M.A., and Calin G.A. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin. Biol. Ther. 9 (2009) 703-711
26. Creighton C.J., Reid J.G., and Gunaratne P.H. Expression profiling of microRNAs by deep sequencing. Brief. Bioinform. 10 (2009) 490-497
27. Davis T.H., Cuellar T.L., Koch S.M., Barker A.J., Harfe B.D., McManus M.T., and Ullian E.M. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J. Neurosci. 28 (2008) 4322-4330
28. Dogini D.B., Ribeiro P.A., Rocha C., Pereira T.C., and Lopes-Cendes I. MicroRNA expression profile in murine central nervous system development. J. Mol. Neurosci. 35 (2008) 331-337
29. Farcomeni A. A review of modern multiple hypothesis testing, with particular attention to the false discovery proportion. Stat. Methods Med. Res. 17 (2008) 347-388
30. Ferretti E., De Smaele E., Di Marcotullio L., Screpanti I., and Gulino A. Hedgehog checkpoints in medulloblastoma: the chromosome 17p deletion paradigm. Trends Mol. Med. 11 (2005) 537-545
31. Ferretti E., De Smaele E., Miele E., Laneve P., Po A., Pelloni M., Paganelli A., Di Marcotullio L., Caffarelli E., Screpanti I., Bozzoni I., and Gulino A. Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. Embo J. (2008)
32. Ferretti E., De Smaele E., Po A., Di Marcotullio L., Tosi E., Espinola M.S., Di Rocco C., Riccardi R., Giangaspero F., Farcomeni A., Nofroni I., Laneve P., Gioia U., Caffarelli E., Bozzoni I., Screpanti I., and Gulino A. MicroRNA profiling in human medulloblastoma. Int. J. Cancer 124 (2009) 568-577
33. Fujita S., Ito T., Mizutani T., Minoguchi S., Yamamichi N., Sakurai K., and Iba H. miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J. Mol. Biol. 378 (2008) 492-504
34. Gabriely G., Wurdinger T., Kesari S., Esau C.C., Burchard J., Linsley P.S., and Krichevsky A.M. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol. Cell. Biol. 28 (2008) 5369-5380
35. Gal H., Pandi G., Kanner A.A., Ram Z., Lithwick-Yanai G., Amariglio N., Rechavi G., and Givol D. MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. Biochem. Biophys. Res. Commun. 376 (2008) 86-90
36. Gangaraju V.K., and Lin H. MicroRNAs: key regulators of stem cells. Nat. Rev. Mol. Cell. Biol. 10 (2009) 116-125
37. Garzia L., Andolfo I., Cusanelli E., Marino N., Petrosino G., De Martino D., Esposito V., Galeone A., Navas L., Esposito S., Gargiulo S., Fattet S., Donofrio V., Cinalli G., Brunetti A., Vecchio L.D., Northcott P.A., Delattre O., Taylor M.D., Iolascon A., and Zollo M. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS ONE 4 (2009) e4998
38. Garzon R., Calin G.A., and Croce C.M. MicroRNAs in Cancer. Annu. Rev. Med. 60 (2009) 167-179
39. Gaur A., Jewell D.A., Liang Y., Ridzon D., Moore J.H., Chen C., Ambros V.R., and Israel M.A. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 67 (2007) 2456-2468
40. Gilad S., Meiri E., Yogev Y., Benjamin S., Lebanony D., Yerushalmi N., Benjamin H., Kushnir M., Cholakh H., Melamed N., Bentwich Z., Hod M., Goren Y., and Chajut A. Serum microRNAs are promising novel biomarkers. PLoS ONE 3 (2008) e3148
41. Godlewski J., Nowicki M.O., Bronisz A., Williams S., Otsuki A., Nuovo G., Raychaudhury A., Newton H.B., Chiocca E.A., and Lawler S. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 68 (2008) 9125-9130
42. Godlewski J., Newton H.B., Chiocca E.A., and Lawler S.E. MicroRNAs and glioblastoma; the stem cell connection. Cell Death Differ. (2009)
43. Gustincich S., Sandelin A., Plessy C., Katayama S., Simone R., Lazarevic D., Hayashizaki Y., and Carninci P. The complexity of the mammalian transcriptome. J. Physiol. 575 (2006) 321-332
44. Hammond S.M. MicroRNAs as oncogenes. Curr. Opin. Genet. Dev. 16 (2006) 4-9
45. Hansen T., Olsen L., Lindow M., Jakobsen K.D., Ullum H., Jonsson E., Andreassen O.A., Djurovic S., Melle I., Agartz I., Hall H., Timm S., Wang A.G., and Werge T. Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE 2 (2007) e873
46. Hasemeier B., Christgen M., Kreipe H., and Lehmann U. Reliable microRNA profiling in routinely processed formalin-fixed paraffin-embedded breast cancer specimens using fluorescence labelled bead technology. BMC Biotechnol. 8 (2008) 90
47. Hebert S.S., Horre K., Nicolai L., Papadopoulou A.S., Mandemakers W., Silahtaroglu A.N., Kauppinen S., Delacourte A., and De Strooper B. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 6415-6420
48. Iorio M.V., Visone R., Di Leva G., Donati V., Petrocca F., Casalini P., Taccioli C., Volinia S., Liu C.G., Alder H., Calin G.A., Menard S., and Croce C.M. MicroRNA signatures in human ovarian cancer. Cancer Res. 67 (2007) 8699-8707
49. Ji J., Yamashita T., Budhu A., Forgues M., Jia H.L., Li C., Deng C., Wauthier E., Reid L.M., Ye Q.H., Qin L.X., Yang W., Wang H.Y., Tang Z.Y., Croce C.M., and Wang X.W. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology 50 (2009) 472-480
50. Ji Q., Hao X., Zhang M., Tang W., Yang M., Li L., Xiang D., Desano J.T., Bommer G.T., Fan D., Fearon E.R., Lawrence T.S., and Xu L. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS ONE 4 (2009) e6816
51. Johnson R., Zuccato C., Belyaev N.D., Guest D.J., Cattaneo E., and Buckley N.J. A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol. Dis. 29 (2008) 438-445
52. Kapsimali M., Kloosterman W.P., de Bruijn E., Rosa F., Plasterk R.H., and Wilson S.W. MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system. Genome Biol. 8 (2007) R173
53. Keller A., Leidinger P., Borries A., Wendschlag A., Wucherpfennig F., Scheffler M., Huwer H., Lenhof H.P., and Meese E. miRNAs in lung cancer-studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 9 (2009) 353
54. Keller A., Leidinger P., Lange J., Borries A., Schroers H., Scheffler M., Lenhof H.P., Ruprecht K., and Meese E. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS ONE 4 (2009) e7440
55. Kim J., Inoue K., Ishii J., Vanti W.B., Voronov S.V., Murchison E., Hannon G., and Abeliovich A. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317 (2007) 1220-1224
56. Klein C., and Schlossmacher M.G. Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder. Neurology 69 (2007) 2093-2104
57. Kong W., Zhao J.J., He L., and Cheng J.Q. Strategies for profiling microRNA expression. J. Cell Physiol. 218 (2009) 22-25
58. Krichevsky A.M., and Gabriely G. miR-21: a small multi-faceted RNA. J. Cell. Mol. Med. 13 (2009) 39-53
59. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A.O., Landthaler M., Lin C., Socci N.D., Hermida L., Fulci V., Chiaretti S., Foa R., Schliwka J., Fuchs U., Novosel A., Muller R.U., Schermer B., Bissels U., Inman J., Phan Q., Chien M., Weir D.B., Choksi R., De Vita G., Frezzetti D., Trompeter H.I., Hornung V., Teng G., Hartmann G., Palkovits M., Di Lauro R., Wernet P., Macino G., Rogler C.E., Nagle J.W., Ju J., Papavasiliou F.N., Benzing T., Lichter P., Tam W., Brownstein M.J., Bosio A., Borkhardt A., Russo J.J., Sander C., Zavolan M., and Tuschl T. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129 (2007) 1401-1414
60. Laneve P., Di Marcotullio L., Gioia U., Fiori M.E., Ferretti E., Gulino A., Bozzoni I., and Caffarelli E. The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 7957-7962
61. Laterza O.F., Lim L., Garrett-Engele P.W., Vlasakova K., Muniappa N., Tanaka W.K., Johnson J.M., Sina J.F., Fare T.L., Sistare F.D., and Glaab W.E. Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin. Chem. 55 (2009) 1977-1983
62. Lee R.C., and Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 294 (2001) 862-864
63. Li K.K., Pang J.C., Ching A.K., Wong C.K., Kong X., Wang Y., Zhou L., Chen Z., and Ng H.K. miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Hum. Pathol. 40 (2009) 1234-1243
64. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., and Golub T.R. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838
65. Lukiw W.J. Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. NeuroReport 18 (2007) 297-300
66. Lukiw W.J., Zhao Y., and Cui J.G. An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J. Biol. Chem. 283 (2008) 31315-31322
67. Maes O.C., Chertkow H.M., Wang E., and Schipper H.M. MicroRNA: implications for Alzheimer disease and other human CNS disorders. Curr. Genomics 10 (2009) 154-168
68. Makeyev E.V., Zhang J., Carrasco M.A., and Maniatis T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol. Cell 27 (2007) 435-448
69. Malzkorn B., Wolter M., Liesenberg F., Grzendowski M., Stuhler K., Meyer H.E., and Reifenberger G. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol. 20 (2010) 539-550
70. Mathivanan S., and Simpson R.J. ExoCarta: a compendium of exosomal proteins and RNA. Proteomics 9 (2009) 4997-5000
71. Mattick J.S., and Makunin I.V. Small regulatory RNAs in mammals. Hum. Mol. Genet. 14 Spec No 1 (2005) R121-R132
72. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., and Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133 (2007) 647-658
73. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., Peterson A., Noteboom J., O'Briant K.C., Allen A., Lin D.W., Urban N., Drescher C.W., Knudsen B.S., Stirewalt D.L., Gentleman R., Vessella R.L., Nelson P.S., Martin D.B., and Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 10513-10518
74. Morin R.D., O'Connor M.D., Griffith M., Kuchenbauer F., Delaney A., Prabhu A.L., Zhao Y., McDonald H., Zeng T., Hirst M., Eaves C.J., and Marra M.A. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res. 18 (2008) 610-621
75. Mraz M., Malinova K., Mayer J., and Pospisilova S. MicroRNA isolation and stability in stored RNA samples. Biochem. Biophys. Res. Commun. 390 (2009) 1-4
76. Nass D., Rosenwald S., Meiri E., Gilad S., Tabibian-Keissar H., Schlosberg A., Kuker H., Sion-Vardy N., Tobar A., Kharenko O., Sitbon E., Yanai G., Elyakim E., Cholakh H., Gibori H., Spector Y., Bentwich Z., Barshack I., and Rosenfeld N. MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol. (2008)
77. Nelson K.M., and Weiss G.J. MicroRNAs and cancer: past, present, and potential future. Mol. Cancer Ther. 7 (2008) 3655-3660
78. Nelson P.T., Baldwin D.A., Kloosterman W.P., Kauppinen S., Plasterk R.H., and Mourelatos Z. RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. Rna 12 (2006) 187-191
79. Northcott P.A., Fernandez L.A., Hagan J.P., Ellison D.W., Grajkowska W., Gillespie Y., Grundy R., Van Meter T., Rutka J.T., Croce C.M., Kenney A.M., and Taylor M.D. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res. 69 (2009) 3249-3255
80. Osaki M., Takeshita F., and Ochiya T. MicroRNAs as biomarkers and therapeutic drugs in human cancer. Biomarkers 13 (2008) 658-670
81. Packer A.N., Xing Y., Harper S.Q., Jones L., and Davidson B.L. The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J. Neurosci. 28 (2008) 14341-14346
82. Palma V., and Ruiz i Altaba A. Hedgehog-GLI signaling regulates the behavior of cells with stem cell properties in the developing neocortex. Development 131 (2004) 337-345
83. Palma V., Lim D.A., Dahmane N., Sanchez P., Brionne T.C., Herzberg C.D., Gitton Y., Carleton A., Alvarez-Buylla A., and Ruiz i Altaba A. Sonic hedgehog controls stem cell behavior in the postnatal and adult brain. Development 132 (2005) 335-344
84. Papagiannakopoulos T., and Kosik K.S. MicroRNAs: regulators of oncogenesis and stemness. BMC Med. 6 (2008) 15
85. Pena J.T., Sohn-Lee C., Rouhanifard S.H., Ludwig J., Hafner M., Mihailovic A., Lim C., Holoch D., Berninger P., Zavolan M., and Tuschl T. miRNA in situ hybridization in formaldehyde and EDC-fixed tissues. Nat. Methods 6 (2009) 139-141
86. Perkins D.O., Jeffries C.D., Jarskog L.F., Thomson J.M., Woods K., Newman M.A., Parker J.S., Jin J., and Hammond S.M. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol. 8 (2007) R27
87. Pierson J., Hostager B., Fan R., and Vibhakar R. Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J. Neurooncol. 90 (2008) 1-7
88. Resnick K.E., Alder H., Hagan J.P., Richardson D.L., Croce C.M., and Cohn D.E. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol. Oncol. 112 (2009) 55-59
89. Rosas H.D., Salat D.H., Lee S.Y., Zaleta A.K., Hevelone N., and Hersch S.M. Complexity and heterogeneity: what drives the ever-changing brain in Huntington's disease?. Ann. N. Y. Acad. Sci. 1147 (2008) 196-205
90. Rousseau A., Mokhtari K., and Duyckaerts C. The 2007 WHO classification of tumors of the central nervous system - what has changed?. Curr. Opin. Neurol. 21 (2008) 720-727
91. Schaefer A., O'Carroll D., Tan C.L., Hillman D., Sugimori M., Llinas R., and Greengard P. Cerebellar neurodegeneration in the absence of microRNAs. J. Exp. Med. 204 (2007) 1553-1558
92. Schetter A.J., and Harris C.C. Plasma microRNAs: a potential biomarker for colorectal cancer?. Gut 58 (2009) 1318-1319
93. Schmittgen T.D., Lee E.J., Jiang J., Sarkar A., Yang L., Elton T.S., and Chen C. Real-time PCR quantification of precursor and mature microRNA. Methods 44 (2008) 31-38
94. Selbach M., Schwanhausser B., Thierfelder N., Fang Z., Khanin R., and Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 455 (2008) 58-63
95. Shimono Y., Zabala M., Cho R.W., Lobo N., Dalerba P., Qian D., Diehn M., Liu H., Panula S.P., Chiao E., Dirbas F.M., Somlo G., Pera R.A., Lao K., and Clarke M.F. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138 (2009) 592-603
96. Silber J., Lim D.A., Petritsch C., Persson A.I., Maunakea A.K., Yu M., Vandenberg S.R., Ginzinger D.G., James C.D., Costello J.F., Bergers G., Weiss W.A., Alvarez-Buylla A., and Hodgson J.G. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 6 (2008) 14
97. Simpson R.J., Lim J.W., Moritz R.L., and Mathivanan S. Exosomes: proteomic insights and diagnostic potential. Expert Rev. Proteomics 6 (2009) 267-283
98. Skog J., Wurdinger T., van Rijn S., Meijer D.H., Gainche L., Sena-Esteves M., Curry Jr. W.T., Carter B.S., Krichevsky A.M., and Breakefield X.O. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10 (2008) 1470-1476
99. Smirnova L., Grafe A., Seiler A., Schumacher S., Nitsch R., and Wulczyn F.G. Regulation of miRNA expression during neural cell specification. Eur. J. NeuroSci. 21 (2005) 1469-1477
100. Stark K.L., Xu B., Bagchi A., Lai W.S., Liu H., Hsu R., Wan X., Pavlidis P., Mills A.A., Karayiorgou M., and Gogos J.A. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 40 (2008) 751-760
101. Talebizadeh Z., Butler M.G., and Theodoro M.F. Feasibility and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autism. Autism Res. 1 (2008) 240-250
102. Trivedi S., and Ramakrishna G. miRNA and neurons. Int. J. Neurosci. 119 (2009) 1995-2016
103. Uziel T., Karginov F.V., Xie S., Parker J.S., Wang Y.D., Gajjar A., He L., Ellison D., Gilbertson R.J., Hannon G., and Roussel M.F. The miR-17 92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 2812-2817
104. Ventura A., and Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 136 (2009) 586-591
105. Vescovi A.L., Galli R., and Reynolds B.A. Brain tumour stem cells. Nat. Rev. Cancer 6 (2006) 425-436
106. Visvanathan J., Lee S., Lee B., Lee J.W., and Lee S.K. The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes Dev. 21 (2007) 744-749
107. Wang W.X., Rajeev B.W., Stromberg A.J., Ren N., Tang G., Huang Q., Rigoutsos I., and Nelson P.T. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 28 (2008) 1213-1223
108. Wang W.X., Wilfred B.R., Baldwin D.A., Isett R.B., Ren N., Stromberg A., and Nelson P.T. Focus on RNA isolation: obtaining RNA for microRNA (miRNA) expression profiling analyses of neural tissue. Biochim. Biophys. Acta 1779 (2008) 749-757
109. Wang J., Chen J., Chang P., LeBlanc A., Li D., Abbruzzesse J.L., Frazier M.L., Killary A.M., and Sen S. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev. Res. (Phila Pa) 2 (2009) 807-813
110. Winter J., Jung S., Keller S., Gregory R.I., and Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 11 (2009) 228-234
111. Winterer G., and Weinberger D.R. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci. 27 (2004) 683-690
112. Wu J., and Xie X. Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biol. 7 (2006) R85
113. Wu M., Jolicoeur N., Li Z., Zhang L., Fortin Y., L'Abbe D., Yu Z., and Shen S.H. Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. Carcinogenesis 29 (2008) 1710-1716
114. Yin J.Q., Zhao R.C., and Morris K.V. Profiling microRNA expression with microarrays. Trends Biotechnol. 26 (2008) 70-76
115. Yu F., Yao H., Zhu P., Zhang X., Pan Q., Gong C., Huang Y., Hu X., Su F., Lieberman J., and Song E. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131 (2007) 1109-1123
116. Zhang B., Pan X., Cobb G.P., and Anderson T.A. microRNAs as oncogenes and tumor suppressors. Dev. Biol. 302 (2007) 1-12
117. Zhang Y., Chao T., Li R., Liu W., Chen Y., Yan X., Gong Y., Yin B., Liu W., Qiang B., Zhao J., Yuan J., and Peng X. MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J. Mol. Med. 87 (2009) 43-51